Atatürk Sanatorium Training and Research Hospital
Ankara, Turkey (Türkiye)
NCT Number: NCT06563011
The aim of this study is to comprehensively evaluate the nutritional status of IPF patients and to evaluate the effectiveness of 3-month dietary counselling. In this study, the nutritional status of IPF patients followed in Atatürk Sanatorium Training and Research Hospital were comprehensively evaluated.
A comprehensive assessment were performed, including nutritional status, anthropometric measurements, body composition, hand dynamometer, pulmonary function, and food frequency. Also quality of life were assessed by SGRQ. Tailored dietary counselling were given to the patients and, patients were assessed at the end of the 3-month follow-up period in terms of same parameters.
Looking for future studies?
Notify Me60 year–84 year
All sexes
Interventional
Not applicable
Ankara, Turkey (Türkiye)
Idiopathic pulmonary fibrosis (IPF) is an irreversible interstitial lung disease of unknown etiology, characterized by progressive loss of lung function. IPF is a disease of advanced age. Preliminary studies of IPF indicate that nutritional status may affect quality of life and prognosis, but the clinical significance of nutritional status has not been investigated. Weight loss is recognized as a common complication of IPF. There is no study that comprehensively evaluates the nutritional status of IPF patients in Turkey. The aim of this study is to comprehensively evaluate the nutritional status of IPF patients and to evaluate the effectiveness of 3-month dietary counselling. In this study, the nutritional status of IPF patients followed in Atatürk Sanatorium Training and Research Hospital were comprehensively evaluated. A comprehensive assessment were performed, including nutritional status, anthropometric measurements, body composition, dynamometer, pulmonary function, and several questionnaires. so quality of life were assessed by SGRQ. All measurements were taken at the baseline. Then, tailored dietary counselling were given to the patients and, patients were assessed at the end of the 3-month follow-up period in terms of same parameters.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Tailored Dietary Counselling
Time frame: 12 weeks
The effect of dietary counselling on change from baseline in FVC values at 12 weeks were assessed.
Time frame: 12 weeks
The effect of dietary counselling on change from baseline in DLCO values at 12 weeks were assessed.
Time frame: 12 weeks
The effect of dietary counselling on change from baseline in BMI (kg/m2) at 12 weeks were assessed.
Time frame: 12 weeks
The effect of dietary counselling on change from baseline in body composition measured by BIA at 12 weeks were assessed.
Time frame: 12 weeks
The effect of dietary counselling on change from baseline in energy intake (kcal/day) at 12 weeks were assessed.
Time frame: 12 weeks
The effect of dietary counselling on change from baseline in carbohydrate, protein and fat intake (kcal/day) at 12 weeks were assessed.
Time frame: 12 weeks
The effect of dietary counselling on change from baseline in St. George Respiratory Questionnaire (SGRQ) score at 12 weeks were assessed. Scores range from 0-100. While score of zero indicates normal, and a score of 100 indicates impaired quality of life.
İrem Çağla Özel
Other
The Assessment of Nutritional Status of Patients With IPF and The Effectiveness of Nutritional Support
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06230822
Idiopathic Pulmonary Fibrosis, Lung Diseases
Beijing, China
View Trial DetailsNCT06335303
Idiopathic Pulmonary Fibrosis, Lung Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT07712952
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
Seoul, South Korea
View Trial DetailsNCT07225296
Idiopathic Pulmonary Fibrosis, Lung Diseases
Baltimore, Maryland, United States
View Trial Details